Exhibit Showcase Sessions are short presentations held at the IASLC 2019 World Conference on Lung Cancer by exhibitors and sponsors. They are not are not sponsored or endorsed by the IASLC and are not part of the official IASLC accredited program.
All Exhibit Showcase Sessions take place in the Exhibit Showcase Theatre, located inside the Exhibit Hall on Level 2, Hall 8.1.
|12:00 - 13:15||EXH01 - Bristol-Myers Squibb Foundation Exhibit Showcase Session - Adressing Inequities in Care and Support for Lung Cancer Patients In The Us and Africa: Lessons and Challenges From the Front Lines|| The Bristol-Myers Squibb Foundation will be hosting a panel at IASLC WCLC in September in Barcelona, Spain with the objective to share lessons from the BMS-F funded projects and programs aiming to address health care disparities for underserved lung cancer patients in the United States and Africa. The panel will cover the multifaceted needs of patients with lung cancer and their families. Key takeaways from the panel will include knowledge and ideas for patient-centered approaches for promoting patient engagement and improving lung cancer prevention, early detection, shared decision making, symptom control, lung cancer screening program management and survivorship care from a variety of care settings and geographies.
View More Details +
12:00 – 12:10 - Registration & Lunch
12:11 – 12:12 - Host Opening Remarks | Catharine Grimes, Bristol-Myers Squibb Foundation
12:13 – 12:20 - Moderator Opening Remarks | Christopher Lathan, MD, MS, MPH, Dana-Farber Cancer Institute
12:21 - 12:29 - Lung Cancer Screening: Are we ready? Educating providers and increasing awareness about their role in lung cancer screening. Lessons from the LuCa National Training Network in the US. | Celeste Worth, MCHES, University of Louisville
12:30 – 12:38 - Establishing a Pan-African collaboration to improve awareness about, data on and intervention for lung cancer. How Secure The Future is trying to rapidly build an African body of knowledge regarding lung cancer in different cultural and resource settings; health systems and within sites with varying risk-profiles and economic development | Chite Asirwa, MD International Cancer Institute, (ICI), Eldoret, Kenya
12:39 – 12:47 - How do we track it? The VAPALS-ELCAP Open Source Lung Screening Management System: Implications for Global Partnerships to Improve Lung Screening Access, Safety, and Efficacy | Drew Moghanaki, MD, MPH, Atlanta Veterans Affairs Health Care System
12:48 – 12:56 - Planning for Survivors: Building Support Services and Survivorship Pathways for Patients Treated for Lung Cancer | Scott Shofer, MD, PhD, Duke University & Durham Veterans Affairs Health Care System
12:57 – 13:05 - Putting it All Together - The Optimal Care Coordination Model (OCCM): The goal of this project is to create sustainable improvements in Medicaid patients’ access to quality lung cancer services and health outcomes by developing a comprehensive, written plan delineating a Medicaid lung cancer patient’s course of treatment and progression using an OCCM for providers, patients and their caregivers | Matthew Smeltzer, PhD, University of Memphis
13:05 – 13:15 - Moderated Discussion and Q&A | Christopher Lathan, MD, MS, MPH, Dana-Farber Cancer Institute
13:15 - Closing Remarks | Catharine Grimes, Bristol-Myers Squibb Foundation
Keep up to date with Conference News & Alerts.